Vascular peroxidase 1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation, apoptosis resistance and migration

Baiyang You,Yanbo Liu,Jia Chen,Xiao Huang,Huihui Peng,Zhaoya Liu,Yixin Tang,Kai Zhang,Qian Xu,Xiaohui Li,Guangjie Cheng,Ruizheng Shi,Guogang Zhang

DOI: https://doi.org/10.1093/cvr/cvx234

IF: 13.081

2017-11-27

Cardiovascular Research

Abstract:Abstract Aims Reactive oxygen species (ROS) play essential roles in the pulmonary vascular remodelling associated with hypoxia-induced pulmonary hypertension (PH). Vascular peroxidase 1 (VPO1) is a newly identified haeme-containing peroxidase that accelerates oxidative stress development in the vasculature. This study aimed to determine the potential role of VPO1 in hypoxia-induced PH-related vascular remodelling. Methods and results The vascular morphology and VPO1 expression were assessed in the pulmonary arteries of Sprague–Dawley (SD) rats. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) and VPO1 expression and HOCl production were significantly increased in hypoxic rats, which also exhibited obvious vascular remodelling. Furthermore, a hypoxia-induced PH model was generated by exposing primary rat pulmonary artery smooth muscle cells (PASMCs) to hypoxic conditions (3% O2, 48 h), which significantly increased the expression of NOX4 and VPO1 and the production of HOCl. These hypoxic changes were accompanied by enhanced proliferation, apoptosis resistance, and migration. In PASMCs, hypoxia-induced changes, including effects on the expression of cell cycle regulators (cyclin B1 and cyclin D1), apoptosis-related proteins (bax, bcl-2, and cleaved caspase-3), migration promoters (matrix metalloproteinases 2 and 9), and NF-κB expression, as well as the production of HOCl, were all inhibited by silencing VPO1 with small interfering RNAs. Moreover, treatment with HOCl under hypoxic conditions upregulated NF-κB expression and enhanced proliferation, apoptosis resistance, and migration in PASMCs, whereas BAY 11-7082 (an inhibitor of NF-κB) significantly inhibited these effects. Conclusion Collectively, these results demonstrate that VPO1 promotes hypoxia-induced proliferation, apoptosis resistance, and migration in PASMCs via the NOX4/VPO1/HOCl/NF-κB signalling pathway.

cardiac & cardiovascular systems

What problem does this paper attempt to address?

Based on the provided text content, this study aims to explore the potential role of vascular peroxidase 1 (VPO1) in hypoxia - induced pulmonary hypertension (PH) - related vascular remodeling. Specifically, the study focuses on how VPO1 promotes the proliferation, anti - apoptosis and migration abilities of pulmonary artery smooth muscle cells (PASMCs) under hypoxic conditions through the NOX4/VPO1/HOCl/NF - κB signaling pathway. The study experimentally verified the up - regulation of VPO1 expression in a hypoxic environment, and this up - regulation is closely related to the functional changes of PASMCs, including the expression changes of cell cycle regulators (such as cyclin B1 and cyclin D1), apoptosis - related proteins (such as bax, bcl - 2 and cleaved caspase - 3), migration - promoting factors (such as MMP2 and MMP9) and NF - κB. In addition, the study also found that silencing VPO1 by small interfering RNA (siRNA) can inhibit these hypoxia - induced functional changes of PASMCs, thus revealing the important role that VPO1 may play in hypoxia - induced pulmonary hypertension.